US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Incyte

112.75

-0.6900-0.61%

Post-market: 112.750.00000.00%19:30 EDT

Volume:1.93M

Turnover:216.34M

Market Cap:22.85B

PE:14.36

High:113.75

Open:112.89

Low:110.08

Close:113.44

52wk High:132.60

52wk Low:82.82

Shares:202.70M

Float Shares:169.82M

Volume Ratio:0.94

T/O Rate:1.13%

Dividend:- -

Dividend Rate:- -

EPS(TTM):7.85

EPS(LYR):6.41

ROE:30.67%

ROA:16.83%

PB:3.60

PE(LYR):17.59

Loading ...

Overview Company News Filings

Incyte price target raised to $136 from $124 at BofA

Incyte : Bofa Global Research Raises Price Objective to $136 from $124

THOMSON REUTERS

Incyte: Early Strength in VGA039 Offsets Execution Risks; Salveen Richter Reiterates Hold and $100 Price Target

Incyte is Maintained at Overweight by Barclays

Incyte: VGA039 Data Reinforces Diversification Strategy as Analyst Reiterates Hold and Keeps $103 Price Target Unchanged

Incyte price target raised to $134 from $117 at Barclays

Incyte Corp. Stock Outperforms Competitors Despite Losses on the Day

Hemab Therapeutics' HMB-002 Well Suited for Type 1 Von Willebrand Disease, Wedbush Says

MT Newswires Live

Jefferies Adjusts Price Target on Incyte to $105 From $100, Maintains Hold Rating

MT Newswires Live

Incyte announces safety, efficacy data from VGA039 study

Incyte's Latarcibart Cuts Bleeding Rates in Phase 1/2 Trial in Patients With von Willebrand Disease

MT Newswires Live

Incyte - Phase 3 Vivid-6 Trial of Latarcibart for Vwd Currently Enrolling

THOMSON REUTERS

Incyte - Latarcibart Treatment Led to 81% Median Reduction in Annualized Bleeding Rate in Vwd

THOMSON REUTERS

Incyte - Presents Phase 1/2 Data for Latarcibart Showing Substantial Bleed Reductions in Vwd Patients

THOMSON REUTERS

Incyte Says Phase 1/2 Data Show 81% Median Bleed-rate Cut with VWD Drug Latarcibart

Incyte (INCY) Could Be 8% Overvalued After Its 22% Three Month Run

Simply Wall St.

Incyte Corp. Stock Outperforms Competitors Despite Losses on the Day

Does Opzelura’s EU Setback and Index Exit Reframe the Bull Case For Incyte (INCY)?

Simply Wall St.

Incyte Corp. Stock Outperforms Competitors on Strong Trading Day

Press Release: Incyte to Report Second Quarter Financial Results

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/INCY/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"INCY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INCY\",,,,,undefined,":{"symbol":"INCY","market":"US","secType":"STK","nameCN":"Incyte","latestPrice":112.75,"timestamp":1791489600000,"preClose":113.44,"halted":0,"volume":1927035,"hourTrading":{"tag":"盘后","latestPrice":112.75,"preClose":112.75,"latestTime":"19:30 EDT","volume":62189,"amount":7011822.560934001,"timestamp":1791502204109,"change":0,"changeRate":0,"amplitude":0.002572},"delay":0,"changeRate":-0.006082510578279247,"floatShares":169819727,"shares":202697746,"eps":7.85,"marketStatus":"Post-Mkt","change":-0.69,"latestTime":"10-08 19:53:18 EDT","open":112.89,"high":113.75,"low":110.08,"amount":216343567.58751,"amplitude":0.032352,"askPrice":113.13,"askSize":1,"bidPrice":111,"bidSize":40,"shortable":3,"etf":0,"ttmEps":7.85,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1791504000000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":113.44,"preHourTrading":{"tag":"盘前","latestPrice":112.74,"preClose":113.44,"latestTime":"09:26 EDT","volume":723,"amount":81612.28338,"timestamp":1791466010005,"change":-0.7,"changeRate":-0.006171,"amplitude":0.014633},"postHourTrading":{"tag":"盘后","latestPrice":112.75,"preClose":112.75,"latestTime":"19:30 EDT","volume":62189,"amount":7011822.560934001,"timestamp":1791502204109,"change":0,"changeRate":0,"amplitude":0.002572},"volumeRatio":0.942945,"impliedVol":0.4392,"impliedVolPercentile":0.8526},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INCY\",,,,,undefined,":{"symbol":"INCY","floatShares":169819727,"roa":"16.83%","roe":"30.67%","lyrEps":6.41,"volumeRatio":0.942945,"shares":202697746,"dividePrice":0,"high":113.75,"amplitude":0.032352,"preClose":113.44,"low":110.08,"week52Low":82.815,"pbRate":"3.60","psRate":"3.93","week52High":132.6,"institutionHeld":0.9196,"latestPrice":112.75,"committee":0.95122,"eps":7.85,"divideRate":0,"volume":1927035,"delay":0,"ttmEps":7.85,"open":112.89,"prevYearClose":98.77,"prevWeekClose":115.3,"prevMonthClose":121.35,"prevQuarterClose":121.35,"fiveDayClose":117.14,"twentyDayClose":123.28,"sixtyDayClose":115.09},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INCY\",params:#limit:5,,,undefined,":[{"date":"2026-10-29","symbol":"INCY","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1793260800000,"name":null,"time":"Pre-MKt","dateTimestamp":1793246400000,"actualEps":null},{"market":"US","date":"2026-07-28","symbol":"INCY","fiscalQuarterEnding":"2026/06","expectedEps":1.76,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785211200000,"reportTimeType":"pre","actualEps":2.8},{"market":"US","date":"2026-04-28","symbol":"INCY","fiscalQuarterEnding":"2026/03","expectedEps":1.14,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1777348800000,"reportTimeType":"pre","actualEps":1.55},{"market":"US","date":"2026-02-10","symbol":"INCY","fiscalQuarterEnding":"2025/12","expectedEps":1.64,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1770699600000,"reportTimeType":"pre","actualEps":1.09},{"market":"US","date":"2025-10-28","symbol":"INCY","fiscalQuarterEnding":"2025/09","expectedEps":1.38,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1761624000000,"reportTimeType":"pre","actualEps":2.03}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INCY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INCY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2069,"buy":0.2414,"hold":0.5517,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2414,"analysts":29,"updateTime":1787284800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/INCY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"INCY","date":"2026-10-07","current":14.363057,"percent":0.029364,"low":12.870654,"twenty":16.579139,"median":21.408166,"eighty":53.112386,"high":648.145308,"avg":96.929508,"sd":164.872258,"marketCap":22850116906},"quantilePoints":[{"date":"2021-10-08","current":43.095966,"twenty":-126.920152,"median":-53.75838,"eighty":70.390135,"marketCap":14550835874},{"date":"2021-10-15","current":42.880127,"twenty":-126.920152,"median":-53.75838,"eighty":69.308384,"marketCap":14477960235},{"date":"2021-10-22","current":43.03056,"twenty":-126.920152,"median":-53.75838,"eighty":68.891282,"marketCap":14528752347},{"date":"2021-10-29","current":43.808891,"twenty":-126.920152,"median":-53.75838,"eighty":68.326669,"marketCap":14791546317},{"date":"2021-11-05","current":28.040026,"twenty":-126.321891,"median":-53.279085,"eighty":68.258847,"marketCap":14989637337},{"date":"2021-11-12","current":27.110317,"twenty":-125.553074,"median":-52.997601,"eighty":68.258847,"marketCap":14492633446},{"date":"2021-11-19","current":26.655793,"twenty":-125.039639,"median":-47.426815,"eighty":68.258847,"marketCap":14249653767},{"date":"2021-11-26","current":28.254893,"twenty":-123.924854,"median":-46.283755,"eighty":68.258847,"marketCap":15104500458},{"date":"2021-12-03","current":27.180562,"twenty":-122.424514,"median":-43.300979,"eighty":68.258847,"marketCap":14530184852},{"date":"2021-12-10","current":27.023544,"twenty":-120.541483,"median":-41.894137,"eighty":68.258847,"marketCap":14446246417},{"date":"2021-12-17","current":30.118443,"twenty":-119.13698,"median":26.841735,"eighty":68.258847,"marketCap":16100717146},{"date":"2021-12-23","current":30.358101,"twenty":-115.775745,"median":26.911979,"eighty":68.258847,"marketCap":16228833704},{"date":"2021-12-31","current":30.329177,"twenty":-112.581547,"median":27.15577,"eighty":68.258847,"marketCap":16213371361},{"date":"2022-01-07","current":30.242404,"twenty":-111.158033,"median":27.511125,"eighty":68.252065,"marketCap":16166984331},{"date":"2022-01-14","current":30.940719,"twenty":-109.706662,"median":27.854084,"eighty":68.252065,"marketCap":16540289475},{"date":"2022-01-21","current":30.90353,"twenty":-109.122909,"median":28.14746,"eighty":68.252065,"marketCap":16520409320},{"date":"2022-01-28","current":30.672136,"twenty":-107.744794,"median":29.62673,"eighty":68.252065,"marketCap":16396710574},{"date":"2022-02-04","current":30.035802,"twenty":-106.666568,"median":30.077123,"eighty":68.252065,"marketCap":16056539022},{"date":"2022-02-11","current":15.576603,"twenty":-105.677621,"median":30.151499,"eighty":68.252065,"marketCap":14775669617},{"date":"2022-02-18","current":15.989584,"twenty":-103.869131,"median":30.151499,"eighty":68.252065,"marketCap":15167415202},{"date":"2022-02-25","current":15.963918,"twenty":-103.539483,"median":30.151499,"eighty":68.252065,"marketCap":15143069431},{"date":"2022-03-04","current":16.344234,"twenty":-102.763434,"median":30.151499,"eighty":68.252065,"marketCap":15503829489},{"date":"2022-03-11","current":17.251858,"twenty":-101.447128,"median":30.151499,"eighty":68.252065,"marketCap":16364784474},{"date":"2022-03-18","current":17.545844,"twenty":-100.506256,"median":30.151499,"eighty":68.252065,"marketCap":16643654212},{"date":"2022-03-25","current":18.306475,"twenty":-99.373088,"median":30.151499,"eighty":68.252065,"marketCap":17365174328},{"date":"2022-04-01","current":18.651792,"twenty":-97.445558,"median":30.151499,"eighty":68.252065,"marketCap":17692735608},{"date":"2022-04-08","current":19.407757,"twenty":-93.439406,"median":30.151499,"eighty":68.252065,"marketCap":18409829221},{"date":"2022-04-14","current":19.071772,"twenty":-91.423658,"median":30.151499,"eighty":68.252065,"marketCap":18091120948},{"date":"2022-04-22","current":17.867829,"twenty":-89.542294,"median":30.151499,"eighty":68.252065,"marketCap":16949082973},{"date":"2022-04-29","current":17.489847,"twenty":-88.994619,"median":30.151499,"eighty":68.252065,"marketCap":16590536167},{"date":"2022-05-06","current":17.838131,"twenty":-88.883056,"median":30.023406,"eighty":68.021473,"marketCap":16643654212},{"date":"2022-05-13","current":17.781404,"twenty":-88.883056,"median":29.345751,"eighty":67.499248,"marketCap":16590725323},{"date":"2022-05-20","current":17.776656,"twenty":-88.883056,"median":28.029696,"eighty":66.763386,"marketCap":16586295223},{"date":"2022-05-27","current":18.325054,"twenty":-88.883056,"median":27.587568,"eighty":65.832537,"marketCap":17097971799},{"date":"2022-06-03","current":17.558246,"twenty":-88.883056,"median":27.482201,"eighty":65.113631,"marketCap":16382510613},{"date":"2022-06-10","current":16.713095,"twenty":-88.883056,"median":27.06693,"eighty":64.292991,"marketCap":15593952774},{"date":"2022-06-17","current":16.919635,"twenty":-88.883056,"median":26.885121,"eighty":60.086945,"marketCap":15786662133},{"date":"2022-06-24","current":18.562456,"twenty":-88.883056,"median":26.36655,"eighty":58.867713,"marketCap":17319476810},{"date":"2022-07-01","current":18.439007,"twenty":-88.883056,"median":19.147526,"eighty":58.036609,"marketCap":17204294204},{"date":"2022-07-08","current":19.106106,"twenty":-88.883056,"median":19.102104,"eighty":57.517697,"marketCap":17826723285},{"date":"2022-07-15","current":18.999276,"twenty":-88.883056,"median":18.925681,"eighty":56.936909,"marketCap":17727046030},{"date":"2022-07-22","current":19.205815,"twenty":-88.883056,"median":18.904315,"eighty":56.208463,"marketCap":17919755389},{"date":"2022-07-29","current":18.441381,"twenty":-88.883056,"median":18.878115,"eighty":55.366109,"marketCap":17206509254},{"date":"2022-08-05","current":16.913825,"twenty":-88.883056,"median":18.721515,"eighty":55.122825,"marketCap":15983801593},{"date":"2022-08-12","current":17.415237,"twenty":-88.883056,"median":18.588795,"eighty":54.717821,"marketCap":16457642683},{"date":"2022-08-19","current":17.544692,"twenty":-88.883056,"median":18.439007,"eighty":54.475943,"marketCap":16579979532},{"date":"2022-08-26","current":16.824451,"twenty":-88.883056,"median":18.331526,"eighty":53.5014,"marketCap":15899341789},{"date":"2022-09-02","current":16.525528,"twenty":-88.883056,"median":18.243478,"eighty":52.597171,"marketCap":15616854883},{"date":"2022-09-09","current":16.99392,"twenty":-88.883056,"median":18.047294,"eighty":52.079665,"marketCap":16059491847},{"date":"2022-09-16","current":16.200713,"twenty":-88.883056,"median":17.954707,"eighty":50.829148,"marketCap":15309900607},{"date":"2022-09-23","current":15.74409,"twenty":-88.883056,"median":17.867829,"eighty":50.44787,"marketCap":14878385175},{"date":"2022-09-30","current":15.685246,"twenty":-88.883056,"median":17.800396,"eighty":50.239968,"marketCap":14822777516},{"date":"2022-10-07","current":16.10421,"twenty":-88.883056,"median":17.744168,"eighty":50.010331,"marketCap":15218704046},{"date":"2022-10-14","current":16.264264,"twenty":-88.883056,"median":17.643549,"eighty":49.808517,"marketCap":15369956878},{"date":"2022-10-21","current":16.612615,"twenty":-88.883056,"median":17.544692,"eighty":49.590775,"marketCap":15699154218},{"date":"2022-10-28","current":17.558814,"twenty":-88.883056,"median":17.448189,"eighty":49.403714,"marketCap":16593325371},{"date":"2022-11-04","current":19.630562,"twenty":-88.883056,"median":17.448189,"eighty":49.110861,"marketCap":17197353676},{"date":"2022-11-11","current":19.688971,"twenty":-88.883056,"median":17.448189,"eighty":48.910553,"marketCap":17248523034},{"date":"2022-11-18","current":19.668655,"twenty":-88.883056,"median":17.448189,"eighty":48.59263,"marketCap":17230724996},{"date":"2022-11-25","current":19.874357,"twenty":-88.883056,"median":17.448189,"eighty":48.454449,"marketCap":17410930125},{"date":"2022-12-02","current":21.111107,"twenty":-88.883056,"median":17.448189,"eighty":48.041963,"marketCap":18494385654},{"date":"2022-12-09","current":20.910485,"twenty":-88.883056,"median":17.448189,"eighty":47.59851,"marketCap":18318630035},{"date":"2022-12-16","current":20.831759,"twenty":-88.883056,"median":17.448189,"eighty":47.263641,"marketCap":18249662640},{"date":"2022-12-23","current":20.661611,"twenty":-88.883056,"median":17.448189,"eighty":47.016101,"marketCap":18100604076},{"date":"2022-12-30","current":20.3975,"twenty":-88.883056,"median":17.448189,"eighty":46.554796,"marketCap":17869229589},{"date":"2023-01-06","current":20.537174,"twenty":-88.211139,"median":17.541628,"eighty":46.554796,"marketCap":17991591097},{"date":"2023-01-13","current":20.527016,"twenty":-87.440338,"median":17.558814,"eighty":46.554796,"marketCap":17982692078},{"date":"2023-01-20","current":21.128884,"twenty":-86.920554,"median":17.688817,"eighty":46.554796,"marketCap":18509958937},{"date":"2023-01-27","current":21.763766,"twenty":-86.375415,"median":17.776656,"eighty":46.554796,"marketCap":19066147607},{"date":"2023-02-03","current":21.233005,"twenty":-85.224284,"median":17.831258,"eighty":46.554796,"marketCap":18601173879},{"date":"2023-02-10","current":51.876379,"twenty":-84.628433,"median":17.926219,"eighty":47.016101,"marketCap":17672207326},{"date":"2023-02-17","current":51.706207,"twenty":-84.430663,"median":18.016432,"eighty":47.263641,"marketCap":17614236422},{"date":"2023-02-24","current":50.410279,"twenty":-84.430663,"median":18.075782,"eighty":47.465954,"marketCap":17172765686},{"date":"2023-03-03","current":50.763714,"twenty":-84.430663,"median":18.306475,"eighty":47.986899,"marketCap":17293166796},{"date":"2023-03-10","current":47.131189,"twenty":-84.430663,"median":18.365412,"eighty":48.204376,"marketCap":16055710946},{"date":"2023-03-17","current":48.184949,"twenty":-84.430663,"median":18.530464,"eighty":48.335268,"marketCap":16414684625},{"date":"2023-03-24","current":45.966163,"twenty":-84.430663,"median":18.651792,"eighty":48.401919,"marketCap":15658833214},{"date":"2023-03-31","current":47.301362,"twenty":-84.412914,"median":18.778445,"eighty":48.397883,"marketCap":16113681850},{"date":"2023-04-06","current":48.28967,"twenty":-84.412914,"median":18.882782,"eighty":48.397883,"marketCap":16450359028},{"date":"2023-04-14","current":49.304159,"twenty":-84.430663,"median":19.071772,"eighty":48.454449,"marketCap":16795954805},{"date":"2023-04-21","current":48.335486,"twenty":-84.430663,"median":19.139343,"eighty":48.50111,"marketCap":16465966579},{"date":"2023-04-28","current":48.204584,"twenty":-84.430663,"median":19.205815,"eighty":48.553797,"marketCap":16421373575},{"date":"2023-05-05","current":45.522611,"twenty":-84.430663,"median":19.457874,"eighty":48.598963,"marketCap":14766214974},{"date":"2023-05-12","current":44.133343,"twenty":-84.430663,"median":19.577232,"eighty":48.598963,"marketCap":14315576596},{"date":"2023-05-19","current":43.761954,"twenty":-65.975243,"median":19.668655,"eighty":48.598963,"marketCap":14195108910},{"date":"2023-05-26","current":43.239259,"twenty":-63.609535,"median":19.757538,"eighty":48.598963,"marketCap":14025561798},{"date":"2023-06-02","current":42.30391,"twenty":-63.241519,"median":19.876896,"eighty":48.598963,"marketCap":13722161702},{"date":"2023-06-09","current":42.30391,"twenty":-62.97873,"median":20.184179,"eighty":48.598963,"marketCap":13722161702},{"date":"2023-06-16","current":43.03981,"twenty":-62.654259,"median":20.2337,"eighty":48.609617,"marketCap":13960866189},{"date":"2023-06-23","current":42.579013,"twenty":-62.203628,"median":20.44829,"eighty":48.620272,"marketCap":13811397024},{"date":"2023-06-30","current":42.537748,"twenty":-61.715907,"median":20.562569,"eighty":48.630926,"marketCap":13798011726},{"date":"2023-07-07","current":43.232382,"twenty":-61.507591,"median":20.746685,"eighty":48.630926,"marketCap":14023330915},{"date":"2023-07-14","current":42.599646,"twenty":-61.285022,"median":20.93842,"eighty":48.630926,"marketCap":13818089673},{"date":"2023-07-21","current":44.023302,"twenty":-60.953261,"median":21.128884,"eighty":48.639436,"marketCap":14279882467},{"date":"2023-07-28","current":43.108586,"twenty":-60.731546,"median":21.301572,"eighty":48.639436,"marketCap":13983175020},{"date":"2023-08-04","current":39.731882,"twenty":-60.438616,"median":21.456483,"eighty":48.639436,"marketCap":14561218421},{"date":"2023-08-11","current":40.05595,"twenty":-60.194533,"median":21.842492,"eighty":48.639436,"marketCap":14679984899},{"date":"2023-08-18","current":39.261068,"twenty":-59.937514,"median":26.841735,"eighty":48.639436,"marketCap":14388670895},{"date":"2023-08-25","current":39.273297,"twenty":-59.653506,"median":26.936772,"eighty":48.639436,"marketCap":14393152649},{"date":"2023-09-01","current":39.456731,"twenty":-59.512326,"median":27.180562,"eighty":48.639436,"marketCap":14460378958},{"date":"2023-09-08","current":38.796367,"twenty":-59.369499,"median":27.531785,"eighty":48.639436,"marketCap":14218364247},{"date":"2023-09-15","current":38.814711,"twenty":-59.210021,"median":27.887141,"eighty":48.639436,"marketCap":14225086878},{"date":"2023-09-22","current":35.959249,"twenty":-58.96037,"median":28.341665,"eighty":48.639436,"marketCap":13178597342},{"date":"2023-09-29","current":35.83696,"twenty":-58.783922,"median":29.746559,"eighty":48.639436,"marketCap":13133779803},{"date":"2023-10-06","current":35.959249,"twenty":-58.648658,"median":30.184555,"eighty":48.639436,"marketCap":13178597342},{"date":"2023-10-13","current":34.589606,"twenty":-58.325093,"median":30.329177,"eighty":48.639436,"marketCap":12676640906},{"date":"2023-10-20","current":34.020959,"twenty":-58.123791,"median":30.432478,"eighty":48.639436,"marketCap":12468239349},{"date":"2023-10-23","current":33.709121,"twenty":-58.104138,"median":30.444874,"eighty":48.639436,"marketCap":12353954625},{"date":"2023-11-03","current":28.460509,"twenty":-57.44054,"median":30.568835,"eighty":48.673477,"marketCap":12095175574},{"date":"2023-11-10","current":27.695867,"twenty":-57.041687,"median":30.568835,"eighty":48.673477,"marketCap":11770217179},{"date":"2023-11-17","current":28.471056,"twenty":-56.859827,"median":30.568835,"eighty":48.673477,"marketCap":12099657759},{"date":"2023-11-24","current":28.339221,"twenty":-56.671737,"median":30.568835,"eighty":48.673477,"marketCap":12043630450},{"date":"2023-12-01","current":28.655625,"twenty":-56.44742,"median":30.568835,"eighty":48.673477,"marketCap":12178095992},{"date":"2023-12-08","current":29.09859,"twenty":-55.919657,"median":30.566769,"eighty":48.664967,"marketCap":12366347752},{"date":"2023-12-15","current":33.665349,"twenty":-55.635877,"median":30.642536,"eighty":48.664967,"marketCap":14307133753},{"date":"2023-12-22","current":32.531569,"twenty":-55.314549,"median":30.804361,"eighty":48.664967,"marketCap":13825298892},{"date":"2023-12-29","current":33.080002,"twenty":-54.86823,"median":30.90353,"eighty":48.673477,"marketCap":14058372499},{"date":"2024-01-05","current":35.115533,"twenty":-54.444299,"median":31.099803,"eighty":48.675257,"marketCap":14923434158},{"date":"2024-01-12","current":33.280391,"twenty":-54.278027,"median":32.355824,"eighty":48.675257,"marketCap":14143534010},{"date":"2024-01-19","current":32.262626,"twenty":-54.097036,"median":32.479514,"eighty":48.677037,"marketCap":13711003180},{"date":"2024-01-26","current":32.125518,"twenty":-53.861692,"median":32.505541,"eighty":48.675257,"marketCap":13652734778},{"date":"2024-02-02","current":31.197401,"twenty":-53.506891,"median":32.505541,"eighty":48.675257,"marketCap":13258302520},{"date":"2024-02-09","current":30.24819,"twenty":-53.144235,"median":32.505541,"eighty":48.675257,"marketCap":12854905891},{"date":"2024-02-16","current":22.155837,"twenty":-52.564683,"median":32.440893,"eighty":48.588308,"marketCap":13240305768},{"date":"2024-02-23","current":22.884721,"twenty":-52.564683,"median":32.304813,"eighty":48.499532,"marketCap":13675886456},{"date":"2024-03-01","current":21.926651,"twenty":-52.492457,"median":32.083331,"eighty":48.414027,"marketCap":13103344830},{"date":"2024-03-08","current":22.178379,"twenty":-52.492457,"median":31.44525,"eighty":48.309305,"marketCap":13253777335},{"date":"2024-03-15","current":21.99428,"twenty":-52.492457,"median":30.994435,"eighty":48.204584,"marketCap":13143759533},{"date":"2024-03-22","current":21.686194,"twenty":-52.492457,"median":30.891134,"eighty":48.099863,"marketCap":12959648108},{"date":"2024-03-28","current":21.460766,"twenty":-52.492457,"median":30.738249,"eighty":47.955422,"marketCap":12824932431},{"date":"2024-04-05","current":20.660496,"twenty":-52.564683,"median":30.61994,"eighty":47.58148,"marketCap":12346691778},{"date":"2024-04-12","current":20.634196,"twenty":-52.564683,"median":30.4676,"eighty":47.410327,"marketCap":12330974949},{"date":"2024-04-19","current":19.845197,"twenty":-52.564683,"median":30.368431,"eighty":47.294817,"marketCap":11859470080},{"date":"2024-04-26","current":19.229027,"twenty":-52.492457,"median":30.308517,"eighty":47.22407,"marketCap":11491247231},{"date":"2024-05-03","current":15.991635,"twenty":-52.492457,"median":30.184555,"eighty":46.833129,"marketCap":11920868470},{"date":"2024-05-10","current":16.115134,"twenty":-52.492457,"median":29.750691,"eighty":46.53527,"marketCap":12012930178},{"date":"2024-05-17","current":17.127225,"twenty":-52.492457,"median":29.110225,"eighty":46.400692,"marketCap":12767387101},{"date":"2024-05-24","current":17.329127,"twenty":-52.492457,"median":28.924568,"eighty":45.817215,"marketCap":12917894069},{"date":"2024-05-31","current":17.283882,"twenty":-52.492457,"median":28.845467,"eighty":45.631052,"marketCap":12884165886},{"date":"2024-06-07","current":17.6187,"twenty":-52.492457,"median":28.618711,"eighty":45.300146,"marketCap":13133754440},{"date":"2024-06-14","current":18.909713,"twenty":-52.564683,"median":28.448595,"eighty":45.014977,"marketCap":14096131927},{"date":"2024-06-21","current":18.810172,"twenty":-52.636909,"median":28.254893,"eighty":44.814222,"marketCap":14021929925},{"date":"2024-06-28","current":18.505517,"twenty":-52.853586,"median":28.029696,"eighty":44.545997,"marketCap":13794826826},{"date":"2024-07-05","current":17.392472,"twenty":-52.853586,"median":27.883789,"eighty":44.45557,"marketCap":12965113525},{"date":"2024-07-12","current":18.789057,"twenty":-52.853586,"median":27.625789,"eighty":44.208996,"marketCap":14006190106},{"date":"2024-07-15","current":19.202302,"twenty":-52.853586,"median":27.587568,"eighty":44.133343,"marketCap":14314240843},{"date":"2024-08-02","current":127.521095,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12407164899},{"date":"2024-08-09","current":122.295145,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":11898706108},{"date":"2024-08-16","current":122.097192,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":11879446305},{"date":"2024-08-23","current":124.749758,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12137527661},{"date":"2024-08-30","current":130.470589,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12694135959},{"date":"2024-09-06","current":124.630986,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12125971779},{"date":"2024-09-13","current":125.422797,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12203010990},{"date":"2024-09-20","current":132.271958,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12869400164},{"date":"2024-09-27","current":128.926558,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12543909498},{"date":"2024-10-04","current":132.707454,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12911771730},{"date":"2024-10-11","current":129.401645,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12590133024},{"date":"2024-10-18","current":131.499943,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12794286933},{"date":"2024-10-25","current":129.144306,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":12565095281},{"date":"2024-10-31","current":438.477708,"twenty":-53.175656,"median":27.465673,"eighty":43.695796,"marketCap":14242632908},{"date":"2024-11-08","current":488.35729,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":15862821502},{"date":"2024-11-15","current":461.01545,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":14974703854},{"date":"2024-11-22","current":417.482022,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":13560651027},{"date":"2024-11-29","current":442.392158,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":14369782072},{"date":"2024-12-06","current":444.349383,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":14433356655},{"date":"2024-12-13","current":420.091655,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":13645417136},{"date":"2024-12-20","current":397.731842,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":12919125697},{"date":"2024-12-27","current":412.559304,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":13400751320},{"date":"2025-01-03","current":412.381375,"twenty":-53.191367,"median":27.323117,"eighty":43.655773,"marketCap":13394971812},{"date":"2025-01-10","current":433.73292,"twenty":-53.207078,"median":27.180562,"eighty":43.823852,"marketCap":14088512709},{"date":"2025-01-17","current":429.81847,"twenty":-53.207078,"median":27.180562,"eighty":44.119588,"marketCap":13961363545},{"date":"2025-01-24","current":430.174329,"twenty":-53.207078,"median":27.180562,"eighty":44.284649,"marketCap":13972922559},{"date":"2025-01-31","current":437.52875,"twenty":-53.207078,"median":27.180562,"eighty":44.759202,"marketCap":14211808868},{"date":"2025-02-07","current":444.527312,"twenty":-53.207078,"median":27.180562,"eighty":45.130091,"marketCap":14439136162},{"date":"2025-02-14","current":415.411306,"twenty":-53.207078,"median":27.180562,"eighty":45.522611,"marketCap":13548639743},{"date":"2025-02-21","current":423.540337,"twenty":-53.207078,"median":27.180562,"eighty":45.966163,"marketCap":13813768103},{"date":"2025-02-28","current":434.220817,"twenty":-53.207078,"median":27.180562,"eighty":46.516696,"marketCap":14162111933},{"date":"2025-03-07","current":415.885994,"twenty":-53.209696,"median":27.168166,"eighty":47.237523,"marketCap":13564121691},{"date":"2025-03-14","current":401.764027,"twenty":-53.209696,"median":27.168166,"eighty":47.318409,"marketCap":13103533738},{"date":"2025-03-21","current":359.457462,"twenty":-53.209696,"median":27.168166,"eighty":47.54487,"marketCap":11723705123},{"date":"2025-03-28","current":360.050822,"twenty":-53.209696,"median":27.168166,"eighty":47.729411,"marketCap":11743057558},{"date":"2025-04-04","current":370.612629,"twenty":-53.209696,"median":27.168166,"eighty":48.105099,"marketCap":12087530901},{"date":"2025-04-11","current":327.356688,"twenty":-53.207078,"median":27.180562,"eighty":48.204584,"marketCap":10676738389},{"date":"2025-04-17","current":342.546703,"twenty":-53.207078,"median":27.180562,"eighty":48.30276,"marketCap":11172160725},{"date":"2025-04-25","current":349.904367,"twenty":-53.209696,"median":27.168166,"eighty":48.304069,"marketCap":11412130919},{"date":"2025-05-02","current":564.51072,"twenty":-53.209696,"median":27.168166,"eighty":48.393956,"marketCap":12007143006},{"date":"2025-05-09","current":543.579321,"twenty":-52.564683,"median":27.496923,"eighty":48.460691,"marketCap":11561932157},{"date":"2025-05-16","current":571.154163,"twenty":15.632391,"median":27.625789,"eighty":48.737881,"marketCap":12148449057},{"date":"2025-05-23","current":587.080228,"twenty":15.726225,"median":27.883789,"eighty":49.007354,"marketCap":12487196442},{"date":"2025-05-30","current":601.004158,"twenty":15.826258,"median":28.029696,"eighty":49.252879,"marketCap":12783358441},{"date":"2025-06-06","current":611.924888,"twenty":15.885314,"median":28.339221,"eighty":49.434802,"marketCap":13015642362},{"date":"2025-06-13","current":629.944092,"twenty":15.934986,"median":28.478966,"eighty":49.660105,"marketCap":13398910831},{"date":"2025-06-20","current":621.298514,"twenty":15.990815,"median":28.671445,"eighty":49.822312,"marketCap":13215019394},{"date":"2025-06-27","current":644.414059,"twenty":16.096118,"median":28.856014,"eighty":50.382952,"marketCap":13706687026},{"date":"2025-07-03","current":622.936624,"twenty":16.116941,"median":28.993122,"eighty":50.591002,"marketCap":13249861982},{"date":"2025-07-11","current":640.136773,"twenty":16.200713,"median":29.581278,"eighty":51.047771,"marketCap":13615709157},{"date":"2025-07-18","current":627.395921,"twenty":16.252966,"median":30.035802,"eighty":51.822721,"marketCap":13344711249},{"date":"2025-07-25","current":641.501864,"twenty":16.33326,"median":30.242404,"eighty":52.761862,"marketCap":13644744647},{"date":"2025-08-01","current":16.792668,"twenty":16.378635,"median":30.24819,"eighty":52.992543,"marketCap":14624230499},{"date":"2025-08-08","current":17.534873,"twenty":16.546711,"median":30.24819,"eighty":52.992543,"marketCap":15270594539},{"date":"2025-08-15","current":19.319752,"twenty":16.607924,"median":30.24819,"eighty":52.992543,"marketCap":16824992653},{"date":"2025-08-22","current":19.402718,"twenty":16.798469,"median":30.24819,"eighty":52.992543,"marketCap":16897244826},{"date":"2025-08-29","current":18.768144,"twenty":16.870655,"median":30.24819,"eighty":52.992543,"marketCap":16344613336},{"date":"2025-09-05","current":19.158306,"twenty":16.99751,"median":30.268023,"eighty":53.052464,"marketCap":16684393828},{"date":"2025-09-12","current":19.321995,"twenty":17.085907,"median":30.24819,"eighty":52.992543,"marketCap":16826945414},{"date":"2025-09-19","current":19.283875,"twenty":17.161262,"median":30.24819,"eighty":52.992543,"marketCap":16793748470},{"date":"2025-09-26","current":18.310712,"twenty":17.193493,"median":30.24819,"eighty":52.992543,"marketCap":15946250000},{"date":"2025-10-03","current":19.34666,"twenty":17.274387,"median":30.24819,"eighty":52.992543,"marketCap":16848425790},{"date":"2025-10-10","current":19.003586,"twenty":17.291711,"median":30.24819,"eighty":52.992543,"marketCap":16549653288},{"date":"2025-10-17","current":19.577618,"twenty":17.328736,"median":30.24819,"eighty":52.992543,"marketCap":17049560219},{"date":"2025-10-24","current":20.02608,"twenty":17.356711,"median":30.24819,"eighty":52.992543,"marketCap":17440112509},{"date":"2025-10-31","current":15.211911,"twenty":17.362586,"median":30.24819,"eighty":52.992543,"marketCap":18080618265},{"date":"2025-11-07","current":17.376278,"twenty":17.372241,"median":30.24819,"eighty":52.992543,"marketCap":20653148355},{"date":"2025-11-14","current":17.410964,"twenty":17.400499,"median":30.24819,"eighty":52.992543,"marketCap":20694376123},{"date":"2025-11-21","current":16.80808,"twenty":17.400499,"median":30.24819,"eighty":52.992543,"marketCap":19977798257},{"date":"2025-11-28","current":17.254049,"twenty":17.411313,"median":30.24819,"eighty":52.992543,"marketCap":20507869555},{"date":"2025-12-05","current":16.593354,"twenty":17.411313,"median":30.24819,"eighty":52.992543,"marketCap":19722578743},{"date":"2025-12-12","current":15.873197,"twenty":17.411313,"median":30.24819,"eighty":52.992543,"marketCap":18866611758},{"date":"2025-12-19","current":16.073057,"twenty":17.411313,"median":30.24819,"eighty":52.992543,"marketCap":19104162228},{"date":"2025-12-26","current":16.590051,"twenty":17.411313,"median":30.24819,"eighty":52.992543,"marketCap":19718652289},{"date":"2026-01-02","current":16.314211,"twenty":17.411313,"median":30.24819,"eighty":52.992543,"marketCap":19390793375},{"date":"2026-01-09","current":17.495203,"twenty":17.426189,"median":30.24819,"eighty":52.992543,"marketCap":20794500701},{"date":"2026-01-16","current":17.382885,"twenty":17.442549,"median":30.24819,"eighty":52.992543,"marketCap":20661001263},{"date":"2026-01-23","current":17.353153,"twenty":17.454595,"median":30.24819,"eighty":52.992543,"marketCap":20625663177},{"date":"2026-01-30","current":16.695762,"twenty":17.454595,"median":30.24819,"eighty":52.992543,"marketCap":19844298819},{"date":"2026-02-06","current":16.973254,"twenty":17.454595,"median":30.24819,"eighty":52.992543,"marketCap":20174120960},{"date":"2026-02-13","current":15.583655,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":20050709464},{"date":"2026-02-20","current":15.735238,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":20245743660},{"date":"2026-02-27","current":15.481568,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":19919359903},{"date":"2026-03-06","current":15.054661,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":19370079922},{"date":"2026-03-13","current":14.234876,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":18315303146},{"date":"2026-03-20","current":14.377178,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":18498396473},{"date":"2026-03-27","current":14.270452,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":18361076478},{"date":"2026-04-02","current":14.585992,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":18767066029},{"date":"2026-04-10","current":14.997431,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":19296444562},{"date":"2026-04-17","current":14.743762,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":18970060805},{"date":"2026-04-24","current":14.766963,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":18999912978},{"date":"2026-05-01","current":13.293443,"twenty":17.493061,"median":30.24819,"eighty":52.992543,"marketCap":19033245906},{"date":"2026-05-08","current":13.642279,"twenty":17.433127,"median":30.118443,"eighty":52.992543,"marketCap":19532701294},{"date":"2026-05-15","current":13.622744,"twenty":17.411313,"median":29.746559,"eighty":52.992543,"marketCap":19504731792},{"date":"2026-05-22","current":13.592047,"twenty":17.387328,"median":29.09859,"eighty":52.992543,"marketCap":19460779718},{"date":"2026-05-29","current":13.604605,"twenty":17.36462,"median":28.916658,"eighty":53.052464,"marketCap":19478760112},{"date":"2026-06-05","current":14.126463,"twenty":17.348937,"median":28.776913,"eighty":52.992543,"marketCap":20225945372},{"date":"2026-06-12","current":15.045995,"twenty":17.325325,"median":28.50797,"eighty":52.992543,"marketCap":21542509773},{"date":"2026-06-18","current":13.812511,"twenty":17.289424,"median":28.436682,"eighty":52.992543,"marketCap":19776435523},{"date":"2026-06-26","current":15.004135,"twenty":17.272525,"median":28.112465,"eighty":53.052464,"marketCap":21482575127},{"date":"2026-07-02","current":15.880411,"twenty":17.240692,"median":27.997224,"eighty":53.052464,"marketCap":22737207060},{"date":"2026-07-10","current":16.537618,"twenty":17.19048,"median":27.743327,"eighty":53.052464,"marketCap":23678181010},{"date":"2026-07-17","current":16.276689,"twenty":17.163644,"median":27.552445,"eighty":53.052464,"marketCap":23304588380},{"date":"2026-07-24","current":16.28227,"twenty":17.105678,"median":27.323117,"eighty":53.052464,"marketCap":23312579666},{"date":"2026-07-31","current":15.46146,"twenty":17.048056,"median":27.019412,"eighty":53.112386,"marketCap":24929795780},{"date":"2026-08-07","current":14.881923,"twenty":16.977387,"median":26.862395,"eighty":53.112386,"marketCap":23995359171},{"date":"2026-08-14","current":15.150949,"twenty":16.947387,"median":26.172344,"eighty":53.112386,"marketCap":24429132347},{"date":"2026-08-21","current":15.993227,"twenty":16.887518,"median":22.74195,"eighty":53.112386,"marketCap":25787207246},{"date":"2026-08-28","current":16.058598,"twenty":16.844049,"median":22.291093,"eighty":53.112386,"marketCap":25892610074},{"date":"2026-09-04","current":16.091283,"twenty":16.802832,"median":22.155837,"eighty":53.112386,"marketCap":25945311488},{"date":"2026-09-11","current":15.497917,"twenty":16.767447,"median":21.99428,"eighty":53.112386,"marketCap":24988578126},{"date":"2026-09-18","current":16.043512,"twenty":16.717557,"median":21.842492,"eighty":53.112386,"marketCap":25868286344},{"date":"2026-09-25","current":15.643744,"twenty":16.617022,"median":21.686194,"eighty":53.112386,"marketCap":25223707512},{"date":"2026-10-02","current":14.726038,"twenty":16.590712,"median":21.460766,"eighty":53.112386,"marketCap":23744013966},{"date":"2026-10-07","current":14.171643,"twenty":16.579139,"median":21.408166,"eighty":53.112386,"marketCap":22850116906}],"updateTime":1791498085389},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"INCY\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2651245061","title":"Incyte price target raised to $136 from $124 at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2651245061","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651245061?lang=en_us&edition=fundamental","pubTime":"2026-07-15 19:40","pubTimestamp":1784115617,"startTime":"0","endTime":"0","summary":"BofA raised the firm’s price target on Incyte (INCY) to $136 from $124 and keeps a Buy rating on the shares. The firm will look for updated guidanc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/incyte-price-target-raised-to-136-from-124-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/incyte-price-target-raised-to-136-from-124-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651457242","title":"Incyte : Bofa Global Research Raises Price Objective to $136 from $124","url":"https://stock-news.laohu8.com/highlight/detail?id=2651457242","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651457242?lang=en_us&edition=fundamental","pubTime":"2026-07-15 19:28","pubTimestamp":1784114907,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nFWN43H0YA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IDNA","BK4550","BK4585","BK4139","BK4532","INCY","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651510615","title":"Incyte: Early Strength in VGA039 Offsets Execution Risks; Salveen Richter Reiterates Hold and $100 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2651510615","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651510615?lang=en_us&edition=fundamental","pubTime":"2026-07-14 20:55","pubTimestamp":1784033735,"startTime":"0","endTime":"0","summary":"Goldman Sachs analyst Salveen Richter has maintained their neutral stance on INCY stock, giving a Hold rating yesterday. Salveen Richter has given ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/incyte-early-strength-in-vga039-offsets-execution-risks-salveen-richter-reiterates-hold-and-100-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/incyte-early-strength-in-vga039-offsets-execution-risks-salveen-richter-reiterates-hold-and-100-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651705811","title":"Incyte is Maintained at Overweight by Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2651705811","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651705811?lang=en_us&edition=fundamental","pubTime":"2026-07-14 19:14","pubTimestamp":1784027640,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/INCY/analyst-ratings(END) Dow Jones NewswiresJuly 14, 2026 07:14 ET","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651177281","title":"Incyte: VGA039 Data Reinforces Diversification Strategy as Analyst Reiterates Hold and Keeps $103 Price Target Unchanged","url":"https://stock-news.laohu8.com/highlight/detail?id=2651177281","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651177281?lang=en_us&edition=fundamental","pubTime":"2026-07-14 18:56","pubTimestamp":1784026581,"startTime":"0","endTime":"0","summary":"Analyst Judah Frommer from Morgan Stanley maintained a Hold rating on Incyte and keeping the price target at $103.00. Judah Frommer has given his H...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/incyte-vga039-data-reinforces-diversification-strategy-as-analyst-reiterates-hold-and-keeps-103-price-target-unchanged-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/incyte-vga039-data-reinforces-diversification-strategy-as-analyst-reiterates-hold-and-keeps-103-price-target-unchanged-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651179758","title":"Incyte price target raised to $134 from $117 at Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2651179758","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651179758?lang=en_us&edition=fundamental","pubTime":"2026-07-14 17:40","pubTimestamp":1784022011,"startTime":"0","endTime":"0","summary":"Barclays raised the firm’s price target on Incyte (INCY) to $134 from $117 and keeps an Overweight rating on the shares. The firm adjusted the pric...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/incyte-price-target-raised-to-134-from-117-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/incyte-price-target-raised-to-134-from-117-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651144266","title":"Incyte Corp. Stock Outperforms Competitors Despite Losses on the Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2651144266","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651144266?lang=en_us&edition=fundamental","pubTime":"2026-07-14 05:04","pubTimestamp":1783976640,"startTime":"0","endTime":"0","summary":"DJ Incyte Corp. Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Incyte Corp.  slid 2.12% to $114.23 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.79% to 7,515.34 and Dow Jones Industrial Average  falling 0.26% to 52,498.64.This was the stock's second consecutive day of losses.Incyte Corp. closed 3.98% short of its 52-week high of $118.97, which the company achieved on July 9th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Alnylam Pharmaceuticals Inc.  fell 3.58% to $288.06, Bio-Techne Corp.  rose 0.08% to $71.36, and BioMarin Pharmaceutical Inc.  rose 0.14% to $59.20.Trading volume  remained 307,789 below its 50-day average volume of 1.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled July 13, 2026.This content was created by MarketWatch, ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651110938","title":"Hemab Therapeutics' HMB-002 Well Suited for Type 1 Von Willebrand Disease, Wedbush Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2651110938","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651110938?lang=en_us&edition=fundamental","pubTime":"2026-07-13 22:42","pubTimestamp":1783953729,"startTime":"0","endTime":"0","summary":"Hemab Therapeutics'  HMB-002 is particularly well suited for Type 1 von Willebrand disease patients despite encouraging early data from Incyte's  latarcibart, Wedbush Securities said in a Monday note.The investment firm said in the research note that HMB-002 is particularly well suited for Type 1 patients, who comprise about 75% of the diagnosed Von Willebrand disease population, because it targets restoration of the underlying von Willebrand factor.The analysts noted that HMB-002 has demonstrated encouraging preliminary clinical efficacy, with eight of nine evaluable patients experiencing no treated bleeding events during the 28 days following a single dose.Multidose Part B data expected in late 2026 or early 2027 should provide the first assessment of whether the early efficacy observations translate into durable bleed reduction with chronic dosing, according to the note.Wedbush reiterated its outperform rating and $55 price target on the stock.Shares of Hemab were up 2% in Monday tr","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4588","BK4139","BK4550","IDNA","BK4007","INCY","LENZ","BK4539","COAG","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651210114","title":"Jefferies Adjusts Price Target on Incyte to $105 From $100, Maintains Hold Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2651210114","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651210114?lang=en_us&edition=fundamental","pubTime":"2026-07-13 21:15","pubTimestamp":1783948558,"startTime":"0","endTime":"0","summary":"Incyte (INCY) has an average rating of overweight and mean price target of $114.48, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major bank","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["INCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651197263","title":"Incyte announces safety, efficacy data from VGA039 study","url":"https://stock-news.laohu8.com/highlight/detail?id=2651197263","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651197263?lang=en_us&edition=fundamental","pubTime":"2026-07-13 17:15","pubTimestamp":1783934130,"startTime":"0","endTime":"0","summary":"Incyte (INCY) announced complete safety and efficacy data from all patients enrolled in the Phase 1/2 multidose study of VGA039, a Protein S-target...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/incyte-announces-safety-efficacy-data-from-vga039-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/incyte-announces-safety-efficacy-data-from-vga039-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","INCY","BK4585","BK4588","BK4139","BK4550","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651194198","title":"Incyte's Latarcibart Cuts Bleeding Rates in Phase 1/2 Trial in Patients With von Willebrand Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2651194198","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651194198?lang=en_us&edition=fundamental","pubTime":"2026-07-13 16:33","pubTimestamp":1783931624,"startTime":"0","endTime":"0","summary":"Incyte  said Monday that results from a phase 1/2 trial of latarcibart showed an 81% median reduction in annualized bleeding rate in patients with von Willebrand disease, a type of bleeding disorder.The treatment was also found to be safe and well tolerated.A phase 3 trial for the drug is currently enrolling, the company said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","INCY","IDNA","BK4550","BK4585","BK4588","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651914401","title":"Incyte - Phase 3 Vivid-6 Trial of Latarcibart for Vwd Currently Enrolling","url":"https://stock-news.laohu8.com/highlight/detail?id=2651914401","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651914401?lang=en_us&edition=fundamental","pubTime":"2026-07-13 16:01","pubTimestamp":1783929673,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nFWN43F0B5:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INCY","BK4585","BK4139","BK4532","BK4588","IDNA","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651191463","title":"Incyte - Latarcibart Treatment Led to 81% Median Reduction in Annualized Bleeding Rate in Vwd","url":"https://stock-news.laohu8.com/highlight/detail?id=2651191463","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651191463?lang=en_us&edition=fundamental","pubTime":"2026-07-13 16:01","pubTimestamp":1783929673,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nFWN43F0B5:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4532","BK4588","IDNA","BK4550","INCY","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651019146","title":"Incyte - Presents Phase 1/2 Data for Latarcibart Showing Substantial Bleed Reductions in Vwd Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2651019146","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651019146?lang=en_us&edition=fundamental","pubTime":"2026-07-13 16:01","pubTimestamp":1783929673,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nFWN43F0B5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4139","INCY","BK4532","BK4550","IDNA","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651191457","title":"Incyte Says Phase 1/2 Data Show 81% Median Bleed-rate Cut with VWD Drug Latarcibart","url":"https://stock-news.laohu8.com/highlight/detail?id=2651191457","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651191457?lang=en_us&edition=fundamental","pubTime":"2026-07-13 16:00","pubTimestamp":1783929627,"startTime":"0","endTime":"0","summary":"Incyte says Phase 1/2 data show 81% median bleed-rate cut with VWD drug latarcibartIncyte disclosed Phase 1/2 multidose data for VGA039 (latarcibart) in von Willebrand disease, supporting ongoing pivo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nNDL4CWNMM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4588","IDNA","BK4550","INCY","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651166235","title":"Incyte (INCY) Could Be 8% Overvalued After Its 22% Three Month Run","url":"https://stock-news.laohu8.com/highlight/detail?id=2651166235","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651166235?lang=en_us&edition=fundamental","pubTime":"2026-07-13 01:19","pubTimestamp":1783876775,"startTime":"0","endTime":"0","summary":"Incyte (INCY) stock has drawn investor attention after the latest trading session, with shares closing at US$116.71. That price now sits against a wider performance backdrop across the month and past 3 months.\nSee our latest analysis for Incyte.\nLooking beyond the latest move, Incyte’s share price return of 7.54% over the past month and 22.15% over the past 90 days sits alongside a 1-year total shareholder return of 70.16%, suggesting momentum has been building recently.\nIf you are comparing...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-incy/incyte/news/incyte-incy-could-be-8-overvalued-after-its-22-three-month-r","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-incy/incyte/news/incyte-incy-could-be-8-overvalued-after-its-22-three-month-r","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4550","BK4532","BK4588","INCY","BK4139","BK4585","IDNA","AIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650370001","title":"Incyte Corp. Stock Outperforms Competitors Despite Losses on the Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2650370001","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650370001?lang=en_us&edition=fundamental","pubTime":"2026-07-11 05:04","pubTimestamp":1783717440,"startTime":"0","endTime":"0","summary":"DJ Incyte Corp. Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Incyte Corp.  shed 1.53% to $116.71 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.42% to 7,575.39 and the Dow Jones Industrial Average  rising 0.29% to 52,637.01.Incyte Corp. closed 1.90% below its 52-week high of $118.97, which the company achieved on July 9th.The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Alnylam Pharmaceuticals Inc.  fell 4.49% to $298.76, Bio-Techne Corp.  rose 0.21% to $71.30, and BioMarin Pharmaceutical Inc.  fell 1.42% to $59.12.Trading volume  remained 159,969 below its 50-day average volume of 1.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled July 10, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is pub","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650913811","title":"Does Opzelura’s EU Setback and Index Exit Reframe the Bull Case For Incyte (INCY)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2650913811","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650913811?lang=en_us&edition=fundamental","pubTime":"2026-07-10 20:31","pubTimestamp":1783686691,"startTime":"0","endTime":"0","summary":"In late June 2026, Incyte announced that the EMA’s CHMP issued a positive opinion recommending approval of Opzelura (ruxolitinib) cream for moderate atopic dermatitis in European adults inadequately served by existing topical treatments.\nA day later, the same company was removed from several Russell growth and factor indices, highlighting a contrast between advancing clinical and regulatory momentum for Opzelura and a reduced presence in key equity benchmarks that many institutional...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-incy/incyte/news/does-opzeluras-eu-setback-and-index-exit-reframe-the-bull-ca","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-incy/incyte/news/does-opzeluras-eu-setback-and-index-exit-reframe-the-bull-ca","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["INCY","BK4585","IDNA","BK4532","BK4139","BK4550","BK4156","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650972903","title":"Incyte Corp. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2650972903","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650972903?lang=en_us&edition=fundamental","pubTime":"2026-07-10 05:02","pubTimestamp":1783630920,"startTime":"0","endTime":"0","summary":"DJ Incyte Corp. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Incyte Corp.  rallied 1.07% to $118.52 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.81% to 7,543.64 and the Dow Jones Industrial Average  rising 0.27% to 52,487.41.Incyte Corp. closed 0.21% below its 52-week high of $118.77, which the company achieved on July 8th.The stock outperformed some of its competitors Thursday, as Alnylam Pharmaceuticals Inc.  fell 3.31% to $312.79, Bio-Techne Corp.  rose 0.27% to $71.15, and BioMarin Pharmaceutical Inc.  rose 0.37% to $59.97.Trading volume  remained 466,940 below its 50-day average volume of 1.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled July 9, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jo","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649995861","title":"Press Release: Incyte to Report Second Quarter Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2649995861","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649995861?lang=en_us&edition=fundamental","pubTime":"2026-07-08 20:02","pubTimestamp":1783512120,"startTime":"0","endTime":"0","summary":"WILMINGTON, Del.----July 08, 2026--Incyte  announced today that it has scheduled its second quarter financial results conference call and webcast for 8:00 a.m. ET on Tuesday, July 28, 2026.The schedule for the press release and conference call/webcast is as follows:--  Q2 2026 Press Release: July 28, 2026, at 7:00 a.m. ET","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","INCY","BK4532","BK4585","BK4139","BK4550","IDNA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}